J. Pers. Med. 2012, 2(4), 192-200; doi:10.3390/jpm2040192
An Altered Treatment Plan Based on Direct to Consumer (DTC) Genetic Testing: Personalized Medicine from the Patient/Pin-cushion Perspective
1
Duke Translational Medicine Institute, Durham, NC 27715, USA
2
Department of Obstetrics & Gynecology, University of Virginia, Charlottesville, VA 22908, USA
3
Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC 27705, USA
*
Author to whom correspondence should be addressed.
Received: 3 September 2012 / Revised: 22 October 2012 / Accepted: 25 October 2012 / Published: 30 October 2012
(This article belongs to the Special Issue Untold Stories about Personalized Medicine: If You Thought Personalized Medicine Is for Others to Worry about, Think Again)
Abstract
Direct to consumer (DTC) genomic services facilitate the personalized and participatory aspects of “P4” medicine, but raise questions regarding use of genomic data in providing predictive and preventive healthcare. We illustrate the issues involved by describing a pregnancy management case in which a treatment plan was modified based on a DTC result. A woman whose personal and family history were otherwise unremarkable for thromboembolism learned through DTC testing about the presence of a prothrombin (factor 2) gene mutation (rs1799963). Twice daily injections of enoxaparin were recommended throughout pregnancy for this patient who, without prior knowledge of this mutation, would not have been offered such therapy. Moreover, genetically based medical guidelines are a moving target, and treatment of thrombophilic conditions in asymptomatic patients is controversial. We address the state of the art in actionable personalized medicine with respect to clotting disorders in pregnancy, as well as other factors at play— economics, patient preference, and clinical decision support. We also discuss what steps are needed to increase the utility of genomic data in personalized medicine by collecting information and converting it into actionable knowledge. View Full-TextKeywords:
personalized medicine; direct-to-consumer genetic testing; genetic counseling; thrombophilia; venous thromboembolism; clotting disorders; pregnancy
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
Scifeed alert for new publications
Never miss any articles matching your research from any publisher- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Share & Cite This Article
MDPI and ACS Style
Tenenbaum, J.D.; James, A.; Paulyson-Nuñez, K. An Altered Treatment Plan Based on Direct to Consumer (DTC) Genetic Testing: Personalized Medicine from the Patient/Pin-cushion Perspective. J. Pers. Med. 2012, 2, 192-200.
Related Articles
Article Metrics
Comments
[Return to top]
J. Pers. Med.
EISSN 2075-4426
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert